A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
Completed · Phase 1/Phase 2
Conditions studied: Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
In brief
This is a Phase 1/2 study to evaluate the safety, clinical activity, pharmacokinetics (PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian cancer.
Key facts
- Study ID
- NCT05198804
- Run by
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- People needed
- 117
- Starts
- 2022-01-27
- Expected to finish
- 2026-01-19
- Last updated by the study team
- 2026-03-18
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Women and Infants Hospital of Rhode Island — Providence, Rhode Island, United States
- Texas Oncology-Fort Worth Cancer Center — Fort Worth, Texas, United States
- Arizona Oncology Associates (Wilmot HOPE) - USOR — Tucson, Arizona, United States
- Rocky Mountain Cancer Centers — Aurora, Colorado, United States
- University of Colorado — Aurora, Colorado, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- Karmanos Cancer Institute — Detroit, Michigan, United States
- Spectrum Health System — Grand Rapids, Michigan, United States
- Rutgers New Jersey Medical School — Newark, New Jersey, United States
- Optimum Clinical Research Group- Women's Oncology — Albuquerque, New Mexico, United States
- The Blavatnik Family - Chelsea Medical Center at Mount Sinai — New York, New York, United States
- Willamette Valley Cancer Institute and Research Center — Eugene, Oregon, United States
- MD Anderson Cancer Center, Gynecologic Oncology Center — Texas City, Texas, United States
- University of Virginia — Charlottesville, Virginia, United States
- Virginia Cancer Specialists — Fairfax, Virginia, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Centre Georges François Leclerc — Dijon, France
- Centre Oscar Lambret — Lille, France
- Centre Hospitalier Lyon Sud — Saint-Genis-Laval, France
- ICANS - Institut de cancérologie Strasbourg Europe — Strasbourg, France
- EDOG - Institut Claudius Regaud — Toulouse, France
- Institut Gustave Roussy — Villejuif, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.